You are presumably referring to this ODT article. "Prof Julian Crane, of Otago's Wellington campus, has received $790,319 to lead the study to measure the effect of the oral probiotic, Strep salivarius, to prevent GAS sore throat among a group at high risk of rheumatic fever." http://www.odt.co.nz/campus/universi...ic-fever-fight
That radio interview was with another research project also mentioned in that article, studying school clinic methods instead. That study will take at least 10 months, and it seems likely Blis's will take time too. I agree there could be great payback if it comes out, but bear in mind that scientific studies have a way of coming up with results that "need further research", and that official acceptance of new studies is very slow too.
Meanwhile, BLT's shareprice seems to be involved in the (usual!!) battle between people looking for Blis news versus broader market trends. And it really is very difficult to say what range of news Blis could come out with this year. Obviously we are hoping for geniune GRAS sales (at a profit this time, unlike the ice cream trials!) but there really is no knowing how quickly consumers will go for it. A big variable will presumably be how attractive a food it is. I quoted a few posts back the "milk based formulations" including "beverages". Well, chocoloate milk sounds like it would sell, but vanilla probiotic yoghurt might get a slower uptake. We'll see.